Fees Relating to Biosimilar Biological Products

Fees Relating to Biosimilar Biological Products

In Legislation

Fees Relating to Biosimilar Biological Products in the U.S. Code: Title 21, Chapter 9, Subchapter VII, Part C, Subpart 8

The current, permanent, in-force federal laws regulating fees relating to biosimilar biological products are compiled in the United States Code under Title 21, Chapter 9, Subchapter VII, Part C, Subpart 8. It constitutes “prima facie” evidence of statutes relating to Drugs (including fees relating to biosimilar biological products) of the United States. The reader can further narrow his/her legal research of the general topic (in this case, Drugs General Authority of the US Code, including fees relating to biosimilar biological products) by chapter and subchapter.